<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
CAPSTONE PHARMACY SERVICES, INC.
(Exact name of issuer as specified in charter)
2930 WASHINGTON BOULEVARD
BALTIMORE, MARYLAND 21230
(Address of principal executive offices)
(410) 646-7373
(Issuer's telephone number, including area code)
II. CHANGE IN NAME OF ISSUER
1. Name prior to change: Choice Drug Systems, Inc.
2. Name after change: Capstone Pharmacy Services, Inc.
3. Effective Date of Charter Amendment changing name: October 2, 1995.
4. Date of shareholder approval of change, if required: Not required.
Date: October 3, 1995
CAPSTONE PHARMACY SERVICES, INC.
By: /s/ R. Dirk Allison
-------------------------------------
Name: R. Dirk Allison
-------------------------------------
Title: President and Chief Executive Officer
-------------------------------------
